Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0330 Name of the Signatory :- ANKITA JAINDesignation :- Company Secretary and Compliance Officer Financial Results For The Quarter And Nine Months Ended On December 31, 2017
The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone Financial results for the quarter and nine months ended December 31, 2017 which are enclosed herewith along with the Limited Review Report of the Auditors thereon. Notice Of Board Meeting To Be Held On 09.02.2018 And Notice Of Trading Window
Pursuant to Regulations 29, 30, 33 and other applicable Regulations of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the company will be held on Friday, 9th February, 2018 to consider and approve, inter alia amongst items the Unaudited Financial Results for the quarter & nine months ended on December 31, 2017.... Shareholding for the Period Ended December 31, 2017
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here Statements Of Investor Complaints For The Quarter Ended December 31, 2017
Pursuant to Regulation 13(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Statement of Investor Complaints for the Quarter ended December 31, 2017 is attached. Clarification
With reference to increase in Volume, Nectar Lifesciences Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Nectar Lifesciences Ltd
The Exchange has sought clarification from Nectar Lifesciences Ltd on December 04, 2017, with reference to increase in Volume. The reply is awaited. Appointment of Company Secretary / Compliance Officer
This is to inform you that the Board of Directors of the Company in their meeting held on 11.11.2017 have appointed Ms. Ankita Jain (ACS 37016) as a Company Secretary & Compliance Officer of the Company. She is a commerce graduate and an associate member of the Institute of Company Secretaries of India. She has an experience of approx 4 years in Secretarial and Legal Departments. Financial Results For The Period Ended On 30-09-2017
The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone Financial results for the quarter and half year ended September 30, 2017 which are enclosed herewith along with the Limited Review Report of the Auditors thereon. Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that due to internal restructuring of employees, Mr. Sukhwinder Singh Company Secretary has been elevated to some other department and ipso facto ceased to be a Company Secretary and Compliance Officer of the company with immediate effect. This is for your information and record please.